These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7309782)

  • 1. Alkyl-lysophospholipids inhibit the growth of hypernephroid carcinomas in vitro.
    Berdel WE; Fink U; Egger B; Reichert A; Munder PG; Rastetter J
    J Cancer Res Clin Oncol; 1981; 101(3):325-30. PubMed ID: 7309782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of determining the sensitivity of hypernephroid cancer to cytostatic agents in vitro and clinically].
    Terent'eva TG; Matveev BP; Martochkina GA; Marinbakh EB
    Antibiotiki; 1977 Jul; 22(7):648-52. PubMed ID: 329755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor action of alkyl-lysophospholipids (Review).
    Berdel WE; Bausert WR; Fink U; Rastetter J; Munder PG
    Anticancer Res; 1981; 1(6):345-52. PubMed ID: 7046622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
    Dulisch I; Neumann HA; Löhr GW; Andreesen R
    Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective effect of O-alkyl lysophospholipids on the growth of a human lung giant cell carcinoma cell line.
    Goto I; Hozumi M; Honma Y
    Anticancer Res; 1994; 14(2A):357-62. PubMed ID: 8017834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis.
    Ruiter GA; Verheij M; Zerp SF; van Blitterswijk WJ
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):415-9. PubMed ID: 11173135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by alkyl-lysophospholipids of tritiated thymidine uptake in cells of human malignant urologic tumors.
    Berdel WE; Fink U; Egger B; Reichert A; Munder PG; Rastetter J
    J Natl Cancer Inst; 1981 May; 66(5):813-7. PubMed ID: 6939927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of human solid tumors by alkyl lysophospholipids.
    Runge MH; Andreesen R; Pfleiderer A; Munder PG
    J Natl Cancer Inst; 1980 Jun; 64(6):1301-6. PubMed ID: 6929370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.
    Andreesen R; Modolell M; Oepke GH; Common H; Löhr GW; Munder PG
    Anticancer Res; 1982; 2(1-2):95-100. PubMed ID: 7114806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid.
    Andreesen R; Munder PG
    J Natl Cancer Inst; 1983 Apr; 70(4):623-7. PubMed ID: 6300501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of malignant hypernephroma cells by autologous lysophospholipid incubated macrophages obtained by a new method.
    Berdel WE; Fink U; Egger B; Reichert A; Munder PG; Rastetter J
    Anticancer Res; 1981; 1(3):135-40. PubMed ID: 7342851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
    Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
    Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic growth of 3-Lewis lung carcinoma in mice treated with alkyl-lysophospholipids and lysophospholipid-induced peritoneal macrophages.
    Berdel WE; Munder PG
    Anticancer Res; 1981; 1(6):397-402. PubMed ID: 7344614
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
    Berdel WE; Fromm M; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
    Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
    Wötzel M; Brachwitz H; Langen P; Thierbach V
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines.
    Morimoto H; Broquet C; Principe P; Mencia-Huerta JM; Braquet P; Bonavida B
    Anticancer Res; 1991; 11(6):2223-9. PubMed ID: 1776863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of sulfur analogues of alkyl lysophospholipid and neoplastic cell growth inhibitory properties.
    Morris-Natschke S; Surles JR; Daniel LW; Berens ME; Modest EJ; Piantadosi C
    J Med Chem; 1986 Oct; 29(10):2114-7. PubMed ID: 3761326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical evidence for the role of alkyl-lysophospholipids on liver sialyltransferase.
    Bador H; Morelis R; Louisot P
    Int J Biochem; 1983; 15(9):1137-42. PubMed ID: 6684598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.